Yes, Parkinson’s disease causes hallucinations, and they are far more common than most people expect. Roughly 38% of people with Parkinson’s experience some form of psychotic symptom during the course of their illness, with hallucinations accounting for about 87% of those episodes. The likelihood climbs as the disease progresses: about 10% at the five-year mark, 23% at ten years, and nearly 40% by fifteen years after diagnosis.
What Hallucinations Look and Feel Like
Parkinson’s-related hallucinations don’t all look the same. They tend to follow a progression, starting with subtler experiences that many people dismiss or don’t mention to their doctors, then potentially developing into more vivid ones over time.
The earliest forms are called minor hallucinations, and they often appear before the more recognizable symptoms. There are three main types. Presence hallucinations give you the strong feeling that someone is nearby, even though no one is there. Passage hallucinations involve a brief shadow or figure darting through your peripheral vision. Visual illusions cause you to briefly misperceive a real object as something else, like mistaking a coat on a hook for a person.
More developed hallucinations are vivid and well-formed. People typically see realistic images of other people, animals, or detailed scenes. These visual hallucinations are by far the most common type in Parkinson’s, though hallucinations can occasionally involve other senses like hearing or touch. Early on, most people recognize that what they’re seeing isn’t real. That awareness can fade as the disease advances, which is when hallucinations become more distressing and harder to manage.
Why Parkinson’s Disrupts Perception
The brain relies on a careful balance of chemical messengers to process what you see. Parkinson’s disrupts several of these systems at once. The loss of cells that produce dopamine is the hallmark of the disease, but the serotonin and acetylcholine systems also deteriorate, and all three play roles in how the brain handles visual information.
One compelling explanation is that the brain begins to “fill in” what it expects to see rather than accurately processing what’s actually there. Research has shown that people with Parkinson’s who hallucinate rely more heavily on prior knowledge and expectations when interpreting visual input compared to those who don’t hallucinate. In other words, the brain’s prediction system overrides the weaker incoming visual signals, generating images that aren’t really present.
Each type of hallucination appears to involve different parts of this visual processing network. Presence hallucinations are linked to disruption in a brain region involved in self-awareness and spatial perception. Passage hallucinations seem to involve areas that process motion. Visual illusions may stem from overactivity in the primary visual areas of the brain combined with weakened top-down regulation from regions that normally keep perception in check.
The Role of Medication
Parkinson’s medications themselves can trigger or worsen hallucinations, creating a difficult balancing act. Fewer than 10% of untreated Parkinson’s patients develop psychotic symptoms, but that number jumps to up to 40% among those taking dopamine-boosting drugs. Visual hallucinations tend to increase with both the dose and duration of treatment.
Not all Parkinson’s medications carry equal risk. One large case-control study found significant differences between drugs. Levodopa, the most commonly prescribed Parkinson’s medication, actually carried the lowest risk of psychotic episodes. Certain dopamine agonists (a different class of drug that mimics dopamine) posed a higher risk. The strongest association was found with pergolide, which had roughly twice the odds of triggering psychotic symptoms compared to other treatments.
This means that if hallucinations develop, one of the first steps a neurologist will consider is reviewing and adjusting your medication regimen. Sometimes reducing or switching a specific drug can significantly reduce symptoms without sacrificing motor control.
Other Risk Factors
Beyond medication, the single strongest predictor of hallucinations in Parkinson’s is cognitive decline. People with dementia alongside their Parkinson’s have significantly higher rates of psychotic symptoms. The number of other medical conditions someone has and the total number of medications they take also correlate with increased risk.
Interestingly, age at diagnosis and the severity of motor symptoms don’t reliably predict who will develop hallucinations. Some people experience minor hallucinations very early in the disease, even before motor symptoms are prominent, without showing any measurable differences in cognitive function at that point. However, those who develop well-formed visual hallucinations early do tend to show measurable changes in brain structure, including thinning of the cortex in areas responsible for visual and spatial processing and reduced volume in the hippocampus, a region critical for memory.
Visual hallucinations early in the disease course are also linked to faster cognitive decline and a greater likelihood of progressing to dementia over time. This makes them an important signal to track and report.
How It Differs From Lewy Body Dementia
Parkinson’s disease and dementia with Lewy bodies share similar underlying brain changes, and both can cause vivid visual hallucinations. The key clinical distinction is timing. In Parkinson’s, motor symptoms like tremor, stiffness, and slowness come first, and cognitive changes or hallucinations develop later, at least a year after the movement problems begin. In Lewy body dementia, cognitive difficulties and hallucinations often appear first or within the same year as any motor symptoms.
This “one-year rule” is the primary way clinicians distinguish between the two conditions. If hallucinations and confusion precede or accompany the earliest movement problems, Lewy body dementia is the more likely diagnosis.
Treatment Options
Managing hallucinations starts with adjusting Parkinson’s medications, since reducing the drugs most likely to provoke symptoms can sometimes resolve the problem. When that’s not enough, there are medications specifically aimed at psychotic symptoms. Only two have strong evidence for reducing hallucinations without worsening Parkinson’s motor symptoms. Pimavanserin is generally the first choice for mild to moderate symptoms. It works by targeting serotonin receptors involved in visual processing rather than blocking dopamine, which means it doesn’t make movement worse. Quetiapine is often used when symptoms need to improve quickly. Clozapine is reserved for urgent or treatment-resistant cases because it requires regular blood monitoring.
Most standard antipsychotic medications used in other conditions are not safe for people with Parkinson’s. They block dopamine broadly, which can dramatically worsen motor function and cause dangerous side effects.
Practical Strategies for Caregivers
Medication isn’t the only tool. How you respond to hallucinations matters, especially when the person experiencing them can no longer tell that what they’re seeing isn’t real.
The most effective approach is gentle redirection. When a hallucination occurs, calmly change the subject or introduce a distraction. Speaking in a non-threatening tone, using simple words, maintaining eye contact, and offering reassuring touch can help ground the person. Arguing about whether the hallucination is real is counterproductive and often increases agitation.
Reminiscence techniques can also be useful. Looking through old photos, playing familiar music, or discussing meaningful past experiences can redirect attention and provide comfort. Good lighting throughout the home reduces the shadows and low-contrast environments that tend to trigger visual misperceptions, particularly in the evening.
Caregiver education is a critical piece of the puzzle. Understanding that hallucinations are a neurological symptom of the disease, not a sign of “losing their mind,” helps both the person with Parkinson’s and their family respond with less fear. Many caregivers find that once they understand the pattern, minor hallucinations become manageable parts of daily life rather than emergencies.